Justin P Turner
Overview
Explore the profile of Justin P Turner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
454
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Campeau Calfat A, Turner J, Simard M, Boiteau V, Sirois C
Ther Adv Drug Saf
. 2024 Dec;
15:20420986241309882.
PMID: 39737141
Background: As the number of medications increases, the appropriateness of polypharmacy may become questionable due to the heightened risk of medication-related harm. Objectives: (1) To investigate the relationship between the...
2.
Leung M, Turner J, Marquina C, Ilomaki J, Tran T, Bykov K, et al.
JAMA Netw Open
. 2024 Nov;
7(11):e2444488.
PMID: 39535796
Importance: The increased use of gabapentinoids has been most pronounced in older people who are also susceptible to hip fractures. Objective: To investigate the overall association between gabapentinoids and the...
3.
Gardner D, Turner J, Magalhaes S, Rajda M, Murphy A
JAMA Psychiatry
. 2024 Sep;
81(12):1187-1197.
PMID: 39292452
Importance: Direct-to-patient interventions enabling transitions from long-term benzodiazepine receptor agonist (BZRA) use to cognitive behavioral therapy for insomnia (CBTI) by older adults has the potential to reduce BZRA use and...
4.
Huon J, Sanyal C, Gagnon C, Turner J, Khuong N, Bortolussi-Courval E, et al.
J Am Geriatr Soc
. 2024 Sep;
72(11):3530-3540.
PMID: 39235969
Background: Potentially inappropriate medications (PIMs) are medications whereby the harms may outweigh the benefits for a given individual. Although overprescribed to older adults, their direct costs on the healthcare system...
5.
Zhang F, Lauzon J, Payette J, Courtemanche F, Papillon-Ferland L, Firoozi F, et al.
Br J Clin Pharmacol
. 2024 Aug;
90(11):2939-2946.
PMID: 39155240
Older adults are at risk of adverse drug events during transition of care from hospital to community, thus optimal communication about medications at discharge is essential. Standardization of medication discharge...
6.
Newport K, Langford A, McEvoy A, Kelly D, Smith T, Tannenbaum C, et al.
Can Pharm J (Ott)
. 2024 Aug;
157(4):164-170.
PMID: 39092083
No abstract available.
7.
Phelan E, Williamson B, Balderson B, Cook A, Piccorelli A, Fujii M, et al.
JAMA Netw Open
. 2024 Jul;
7(7):e2424234.
PMID: 39052289
Importance: High-risk medications that contribute to adverse health outcomes are frequently prescribed to older adults. Deprescribing interventions reduce their use, but studies are often not designed to examine effects on...
8.
McInerney B, Cross A, Alderman C, Bhat R, Boyd C, Brandt N, et al.
J Am Med Dir Assoc
. 2024 Jul;
25(9):105118.
PMID: 38950588
Objectives: To produce a consensus list of the top 10 signs and symptoms suggestive of adverse drug events (ADEs) for monitoring in residents of long-term care facilities (LTCFs) who use...
9.
Turner J, Halme A, Caetano P, Langford A, Tannenbaum C
JAMA Netw Open
. 2024 May;
7(5):e2413698.
PMID: 38809554
Importance: Direct-to-consumer education reduces chronic sedative use. The effectiveness of this approach for prescription opioids among patients with chronic noncancer pain remains untested. Objectives: To evaluate the effectiveness of a...
10.
Langford A, Warriach I, McEvoy A, Karaim E, Chand S, Turner J, et al.
BMJ Qual Saf
. 2024 May;
34(1):28-39.
PMID: 38789258
Introduction: Deprescribing () is an integral component of appropriate prescribing. The extent to which deprescribing recommendations are included in clinical practice guidelines is unclear. This scoping review aimed to identify...